Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study

OBJECTIVE: To assess the effects of lisdexamfetamine dimesylate (LDX) on executive function (EF) behaviors in children with attention-deficit/hyperactivity disorder (ADHD). METHODS: This observational, open-label, 7-week, dose-optimization study of LDX (20–70 mg/day) in children with ADHD evaluated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Turgay, Atilla, Ginsberg, Lawrence, Sarkis, Elias, Jain, Rakesh, Adeyi, Ben, Gao, Joseph, Dirks, Bryan, Babcock, Thomas, Scheckner, Brian, Richards, Cynthia, Lasser, Robert, Findling, Robert L.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2010
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3005278/
https://ncbi.nlm.nih.gov/pubmed/21186969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2009.0110
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados